Biostax Corp. operates as a biopharmaceutical company that acquires and develops immune restoration pharmaceutical and medical technology products. The company was formerly known as Immune Therapeutics, Inc. and changed its name to Biostax Corp. in October 2023. Biostax Corp. is based in Winter Park, Florida.
Stock data | 2024 | Change |
---|---|---|
Price | $0.06 | N/A |
Market Cap | $5.02M | N/A |
Shares Outstanding | 83.66M | N/A |
Employees | 0 | N/A |